Point72 Hong Kong’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Point72 Hong Kong’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,472	Closed	-$23.7K	–	850
2023 Q4	$23.7K	Buy	+1,472	New	+$18.8K	﹤0.01%	541
2022 Q4	–	Sell	-6,696	Closed	-$124K	–	1802
2022 Q3	$124K	Buy	+6,696	New	+$105K	﹤0.01%	1171
2022 Q1	–	Sell	-84	Closed	-$1K	–	2451
2021 Q4	$1K	Sell	84 -1,469	-95%	-$27.6K	﹤0.01%	1819
2021 Q3	$53K	Buy	+1,553	New	+$49.6K	﹤0.01%	1512
2021 Q1	–	Sell	-589	Closed	-$34K	–	2300
2020 Q4	$34K	Sell	589 -452	-43%	-$26.8K	﹤0.01%	1324
2020 Q3	$53K	Buy	+1,041	New	+$51K	0.01%	671
2020 Q1	–	Sell	-720	Closed	-$45K	–	1447
2019 Q4	$45K	Buy	720 +709	+6,445%	+$33.7K	0.01%	715
2019 Q3	$0	Sell	11 -948	-99%	-$28.1K	﹤0.01%	1416
2019 Q2	$22K	Buy	+959	New	+$22.4K	0.01%	767
2019 Q1	–	Sell	-26	Closed	-$1K	–	1342
2018 Q4	$1K	Buy	+26	New	+$639	﹤0.01%	827

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Point72 Hong Kong's DCPH Position: Q1 2024 in Review

Point72 Hong Kong sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 1,472 shares — an estimated $23.7K sold.

Point72 Hong Kong first reported a position in DCPH in Q4 2018 and held it in 10 quarters. The position peaked at $124K in Q3 2022. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

Point72 Hong Kong reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Point72 Hong Kong sold 1,472 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $23.7K.
Point72 Hong Kong first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 10 quarters.
Point72 Hong Kong's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $124K in Q3 2022.
177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Point72 Hong Kong's 13F filing for Q1 2024, filed 15 May 2024.